Cartesian Therapeutics
RNAC
#8958
Rank
S$0.24 B
Marketcap
S$7.92
Share price
4.24%
Change (1 day)
-16.23%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2026 (TTM): S-$2.40

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is S-$2.40. In 2021 the company made an earnings per share (EPS) of S-$9.29 an increase over its 2020 EPS that were of S-$26.70.

EPS history for Cartesian Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.40
2021S-$9.29-65.22%
2020S-$26.70-43.44%
2019S-$47.21-58.08%
2018S-$112.62-9.35%
2017S-$124.23-29.16%
2016S-$175.36